{"entity":{"type":"insider","cik":"0001426486","url":"/insider/0001426486","json_url":"/insider/0001426486.json","name":"Bracebridge Capital, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":1,"n_filings":1,"first":"2021-09-21","last":"2021-09-21","span_basis":"filed_date"},"name_variants":[{"name":"Bracebridge Capital, LLC","source":"filing","n_filings":1,"first_seen":"2021-09-21","last_seen":"2021-09-21"}],"transactions":[{"id":4168343,"accession":"0001104659-21-117993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-117993","line_url":"/filing/0001104659-21-117993#line-1","is_derivative":false,"issuer_cik":"0001081816","issuer_name":"Clarus Therapeutics Holdings, Inc.","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001081816","owner_cik":null,"owner_name":"Olifant Fund, Ltd.; Bracebridge Capital, LLC; FFI FUND LTD; FYI Ltd","owner_display_name":"Olifant Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127360.0,"shares_display":"127,360","price_per_share":9.2,"price_display":"9.20","price_state":"stated","total_value":1171712.0,"total_display":"1,171,712.00","total_whole":"1,171,712","shares_owned_after":2102495.0,"shares_owned_after_display":"2,102,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001817944","name":"Clarus Therapeutics Holdings, Inc.","url":"/issuer/0001817944","role":"Ten percent owner","n_filings":1,"first_seen":"2021-09-21","last_seen":"2021-09-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001426486","retrieved_at":"2026-08-22T19:20:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}